STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
12 hedge funds and large institutions have $727K invested in Statera Biopharma, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$493K |
2 |
2
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
$2K |
Top Sellers
1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
3 |
3
BlackRock
New York
|
$23K |